Literature DB >> 5645214

The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.

P J Lachmann, H J Müller-Eberhard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5645214

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  74 in total

1.  Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population.

Authors:  Yingwen Liu; Yanghui Bi; Jia Lin; Lei Cao; Bing He; Zhi Zhang; Yongping Cui; Xuemei Zhang
Journal:  Tumour Biol       Date:  2014-11-15

2.  Immunoconglutinins and C3 in human saliva.

Authors:  B D Williams; S J Challacombe; J M Slaney; P J Lachmann; T Lehner
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

3.  Reaction of an activated complex of guinea-pig complement components, C56, with unsensitized erythrocytes and with erythrocytes carrying C3b molecule.

Authors:  N Tamura; A S Baba
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

4.  The cDNA cloning of conglutinin and identification of liver as a primary site of synthesis of conglutinin in members of the Bovidae.

Authors:  J Lu; S B Laursen; S Thiel; J C Jensenius; K B Reid
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

5.  Inactivator of the third component of complement as an inhibitor in the properdin pathway.

Authors:  C A Alper; F S Rosen; P J Lachmann
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

6.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

7.  Serum-free culture of hamster lymphoid cells and differential inhibition of lipopolysaccharide stimulation by isologous serum.

Authors:  J S Streilein; D A Hart
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

8.  The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation.

Authors:  P J Lachmann; L Halbwachs
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

9.  [Differentiation of human blood lymphocytes by immunologic and autoradiographic methods. I. Results in normal individuals and patients with chronic lymphadenosis].

Authors:  H Huber; G Michlmayr; H Asamer; C Huber; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1972-05-15

10.  Three rat monoclonal antibodies to human C3.

Authors:  P J Lachmann; R G Oldroyd; C Milstein; B W Wright
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.